Medication that protects brain tissue linked to improved stroke survival

Posted on

brain

  • The higher ApTOLL dose showed a neuroprotective effect while the lower dose did not show any effect compared to placebo.
  • Ninety days after treatment, death rates among participants who received the higher dose of ApTOLL were more than four times lower compared to those who received placebo: 4% versus 18%, respectively.
  • Imaging tests given 72 hours after treatment showed that the size of damaged brain tissue was reduced by 40% among the participants who received the higher dose of ApTOLL compared to the placebo group.
  • 64% of participants who received the higher dose of ApTOLL were free of disability at 90 days, compared to 47% of those in the placebo group.

Source: Read Full Article

Related posts:
  1. Sepsis test being trialled for newborn babies could miss 30% of cases
  2. Nearly 500K Aetna members affected by EyeMed security incident
  3. Good Survival, Outcomes With TARE for HCC
  4. Innate and adaptive immune responses to BNT162b2 vaccination in mice
  5. Study proves that antivenom reduces risk of skin necrosis in patients bitten by brown recluse spider
Related posts